HIV drug resistance in adults failing early antiretroviral treatment: results from the HIV Prevention Trials Network 052 trial

Early initiation of antiretroviral therapy (ART) reduces HIV transmission and has health benefits. HIV drug resistance can limit treatment options and compromise use of ART for HIV prevention. We evaluated drug resistance in 85 participants in the HPTN 052 trial who started ART at CD4 counts of 350–...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Acquir Immune Defic Syndr
Auteurs principaux: Fogel, Jessica M., Hudelson, Sarah E., Ou, San-San, Hart, Stephen, Wallis, Carole, Morgado, Mariza G., Saravanan, Shanmugam, Tripathy, Srikanth, Hovind, Laura, Piwowar-Manning, Estelle, Sabin, Devin, McCauley, Marybeth, Gamble, Theresa, Zhang, Xinyi Cindy, Eron, Joseph J., Gallant, Joel E., Kumwenda, Johnstone, Makhema, Joseph, Kumarasamy, Nagalingeswaran, Chariyalertsak, Suwat, Hakim, James, Badal-Faesen, Sharlaa, Akelo, Victor, Hosseinipour, Mina C., Santos, Breno Riegel, Godbole, Sheela V., Pilotto, Jose Henrique, Grinsztejn, Beatriz, Panchia, Ravindre, Mayer, Kenneth H., Chen, Ying Q., Cohen, Myron S., Eshleman, Susan H.
Format: Artigo
Langue:Inglês
Publié: 2016
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4911290/
https://ncbi.nlm.nih.gov/pubmed/26859828
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0000000000000951
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires